INNO — Innocan Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- CA$16.65m
- CA$12.33m
- $26.61m
Annual cashflow statement for Innocan Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.1 | -3.89 | -4.25 | -0.262 | -0.341 |
| Depreciation | |||||
| Non-Cash Items | 4.39 | -1.68 | 1.1 | -0.149 | 0.523 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.969 | -0.531 | -0.793 | -1.2 | 0.271 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.63 | -6.07 | -3.9 | -1.58 | 0.495 |
| Capital Expenditures | -0.041 | -0.026 | -0.046 | -0.015 | -0.016 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.007 | -0.005 | -0.038 | 0.069 | 0.001 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.048 | -0.031 | -0.084 | 0.054 | -0.015 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.3 | 0.125 | 2.92 | 2.7 | 1.15 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.71 | -6.1 | -1.06 | 1.12 | 1.68 |